Humacyte Inc. Common Stock (HUMA)
About The Company
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions.
IPO Year | Sector | Industry |
---|---|---|
2020 | Health Care | Biotechnology: Pharmaceutical Preparations |
Humacyte Inc. (HUMA) Latest News
Company Contact & Address (HUMA)
Corporate Headquarters | Phone | Website |
---|---|---|
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, North Carolina, 27713, United States |
+1 919 313-9633 | Official HUMA Website |
HUMA Key Executives
Ownership and management information.
Key Data Points*
Exchange | Not Available | Market Cap | Not Available |
---|---|---|---|
Sector | Health Care | P/E Ratio | Not Available |
Industry | Biotechnology: Pharmaceutical Preparations | Forward P/E 1 Yr. | Not Available |
1 Year Target | Not Available | Earnings Per Share (EPS) | Not Available |
Today’s High/Low | Not Available | Annualized Dividend | Not Available |
Share Volume | Not Available | Ex Dividend Date | Not Available |
Average Volume | Not Available | Dividend Pay Date | Not Available |
Previous Close | Not Available | Current Yield | Not Available |
52 Week High/Low | Not Available | Beta | Not Available |
* Information and data may delayed
Officers & Directors @ HUMA
Jobs & Employment at Humacyte Inc.
LinkedIn Company Page | https://www.linkedin.com/company/humacyte |
---|---|
Official Career & Employment Page | Careers & Employment at Humacyte Inc. (HUMA) |
Related & Similar Stock Symbols
![]() GPRKGeopark Ltd Common Shares
|
![]() MDGSWMedigus Ltd. Series C Warrant
|
![]() GBABGuggenheim Taxable Municipal Bond & Investment Grade Debt …
|